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The ab T Cell Response to Self-Glycolipids
Shows a Novel Mechanism of CD1b Loading
and a Requirement for Complex Oligosaccharides
the mouse only has homologs of CD1d. The structure
of mouse CD1 has been solved, and, despite its low
sequence homology with classical MHC molecules, it
strikingly resembles that of MHC class I glycoproteins
(Zeng et al., 1997). As for the class I molecules, the a1
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Italy and self-GSLs (our unpublished results) to T cells. The
group II mouse and human CD1d molecules bind and pre-
sent the sphingolipid a-galactosylceramide (a-GalCer),
Summary a compound isolated from marine sponges that stimu-
lates NK (natural killer) T cells (Kawano et al., 1997;
Brossay et al., 1998). However, a-GalCer is not presentThe structural basis for the T cell recognition of lipo-
in normal mammalian cells (Yamaguchi et al., 1996), andglycans remains to be elucidated. We have described
the physiological ligand stimulating NK T cells is notautoreactive T cells responsive to GM1 ganglioside
identified yet.presented by CD1b. We show that glycosphingolipids
Recently, the structures of two different complexesbind to CD1b on the cell surface at neutral pH and
of a classical class I molecule with a glycopeptide haveare recognized without internalization or processing.
been solved (Glithero et al., 1999; Speir et al., 1999). InFurthermore, soluble GM1±CD1b complexes stimulate
both cases, the peptide portion anchors the ligand tospecific T cells. Oligosaccharide groups containing
the MHC groove, with the carbohydrate available for
five or more sugars are required to build a minimal TCR recognition. Based upon these structures, Speir et
epitope for TCR recognition. This suggests a mecha- al. have proposed that the presence of no more than
nism for T cell recognition of glycosphingolipids in one or two sugars is consistent with a mode of antigen
which much of the CD1b-bound ligand is exposed. recognition similar to that carried out by ab TCRs, in
Binding to CD1b is a highly reversible process and which a surface consisting of exposed portions of the
other ceramide-containing glycosphingolipids dis- ligand and a-helical amino acids on the antigen-present-
place GM1. These nonantigenic compounds act as ing molecule are contacted by the TCR (Speir et al.,
1999). A similar model may apply to the recognition ofblockers and may prevent harmful autoreactivity in
lipoglycan antigens, with the carbohydrate exposed butvivo.
with lipid, rather than peptide, responsible for anchoring
the ligand to the antigen-presenting molecule. ThisIntroduction
model is consistent with the small polar head groups or
simple sugars present on many of the lipid antigens
It is now known that T lymphocytes can recognize a presented by CD1 (Porcelli and Modlin, 1999). It has
variety of antigens in addition to peptides, including been presumed that antigens such as LAM, with com-
lipids and glycolipids that are presented by nonpolymor- plex carbohydrate structures, are processed in order to
phic CD1 molecules (Burdin and Kronenberg, 1999; Por- be presented by CD1 molecules. Presentation of purified
celli and Modlin, 1999). Humans have four CD1 proteins LAM by dendritic cells is dependent upon binding to
(CD1a±d), which are divided into two groups on the basis the mannose receptor, followed by internalization and
of their sequence homology (Calabi et al., 1989), while movement to a late endosomal compartment similar to
MIICs, in which CD1b is also routed (Prigozy et al., 1997).
Consistent with this, binding of glycolipids to CD1b wask To whom correspondence should be addressed (e-mail: Gennaro.
DeLibero@unibas.ch). observed to occur only at acidic pH (Ernst et al., 1998),
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Table 1. List of Antigens
Antigen Structurea
1 GM1 b-Gal-(1-3)-b-GalNAc-(1-4)-[a-Neu5Ac-(2-3)]-b-Gal-(1-4)-b-Glc-(1-1)-Cer
2 Asialo±GM1 b-Gal-(1-3)-b-GalNAc-(1-4)-b-Gal-(1-4)-b-Glc-(1-1)-Cer
3 GM2 b-GalNAc-(1-4)-[a-Neu5Ac-(2-3)]-b-Gal-(1-4)-b-Glc-(1-1)-Cer
4 Asialo±GM2 b-GalNAc-(1-4)-b-Gal-(1-4)-b-Glc-(1-1)-Cer
5 GM3 a-Neu5Ac-(2-3)-b-Gal-(1-4)-b-Glc-(1-1)-Cer
6 Lactosylceramide b-Gal-(1-4)-b-Glc-(1-1)-Cer
7 Glucosylceramide b-Glc-(1-1)-Cer
8 Deacylated GM1 b-Gal-(1-3)-b-GalNAc-(1-4)-[a-Neu5Ac-(2-3)]-b-Gal-(1-4)-b-Glc
9 GM1±acetyl GM1 containing acetyl group as acyl moiety
10 Lyso±GM1 GM1 lacking side acyl chain
11 GM1±C24 Contains C24 instead of C18 acyl chain
12 GM1±sphinganine Single bond C4±C5 instead of double bond of sphingosine
13 GM1±Neu5Gc GM1 containing Neu5Gc
14 GM1±alcohol Sialic acid contains CH2OH instead of COOH
15 GalNAc±GD1a b-GalNAc-(1-4)-[a-Neu5Ac-(2-3)]-b-Gal-(1-3)-b-GalNAc-(1-4)-[a-Neu5Ac-(2-3)]-b-Gal-(1-4)-b-Glc-(1-1)-Cer
16 GD1a a-Neu5Ac-(2-3)-b-Gal-(1-3)-b-GalNAc-(1-4)-[a-Neu5Ac-(2-3)]-b-Gal-(1-4)-b-Glc-(1-1)-Cer
17 GD1b b-Gal-(1-3)-b-GalNAc-(1-4)-[a-Neu5Ac-(2-8)-a-Neu5Ac-(2-3)]-b-Gal-(1-4)-b-Glc-(1-1)-Cer
18 GT1b a-Neu5Ac-(2-3)-b-Gal-(1-3)-b-GalNAc-(1-4)-[a-Neu5Ac-(2-8)-a-Neu5Ac-(2-3)]-b-Gal-(1-4)-b-Glc-(1-1)-Cer
19 GQ1b a-Neu5Ac-(2-8)-a-Neu5Ac-(2-3)-b-Gal-(1-3)-b-GalNAc-(1-4)-[a-Neu5Ac-(2-8)-a-Neu5Ac-(2-3)]-b-Gal-(1-4)-
b-Glc-(1-1)-Cer
a Ganglioside nomenclature is in accordance with IUPAC-IUB recommendations (IUPAC, 1977): Cer, ceramide; Neu5Ac, N-acetylneuraminic
acid; Neu5Gc, N-glycolylneuraminic acid.
although direct evidence for processing of lipoglycans antigens is very likely to be buried in the CD1b groove,
with the carbohydrate part exposed for TCR recognition.is lacking.
Several important questions regarding the presenta- Therefore, differences in antigenicity between com-
pounds most likely reflect also differences in the abilitytion of lipid antigens by CD1 molecules remain unan-
swered. First, while the results from several studies sug- of a particular antigen to bind in a stable fashion and in
the correct orientation to CD1b. The solubility and criti-gest that most of the glycolipid±CD1b complexes
expressed by APC are formed intracellularly, predomi- cal micelle concentration also may affect the immune
response to different compounds, by altering the avail-nantly in late endosomes, it remains to be determined
if antigen binding to CD1b can occur elsewhere. Second, ability of the acyl chains for CD1b binding. This will be
true for studies of any lipid antigens. There are twothe stability of lipid antigen-CD1 complexes on APC has
not been assessed in any experimental system. Finally, consequences of this fact. First, as a result of micelle
formation, only a fraction of the GSLs are free as mono-the ability of the TCR to discriminate between different
carbohydrate structures of a natural antigen has not mers in culture and therefore the concentrations re-
quired for T cell activation are probably overestimated.been investigated extensively.
In this study, we have addressed these questions Second, caution must be exercised in concluding that
a glycosphingolipid has less activity than the referencethrough the analysis of the CD1b-mediated presentation
of gangliosides. Because of the autoreactivity of these compound, GM1, especially if it has a more hydrophobic
character.cells and their increased frequency in multiple sclerosis
patients (Shamshiev et al., 1999), this response may As expected, deacylated GM1 (compound #8 in Table
1), which is devoid of the ceramide, was not stimulatorybe relevant for the pathogenesis of multiple sclerosis.
Furthermore, the great variety of gangliosides available (Figure 1A). Lyso±GM1 (#10 in Table 1), a compound
with only the sphingosine tail, and GM1±acetyl (#9), withpermits a more detailed analysis of structure function
relationships than has been carried out previously, par- an acetyl group substituting for the long fatty acid typical
of ceramide, also were unable to stimulate GM1-reactiveticularly regarding the recognition of different carbohy-
drate structures. Here we show that the recognition of T cell clones (Figure 1A). Therefore, both the sphingosine
and the acyl chain are important for antigenicity of thethese self-antigens can occur without antigen pro-
cessing and requires the presence of complex oligosac- gangliosides, likely because they are required for stable
anchoring of GM1 to CD1b. The length of the fatty acidcharides. Additionally, the mechanism for association
of antigen with CD1b is strikingly different from that present in the ceramide also may be important. Indeed,
GM1 with stearic fatty acid (containing 18 C atoms) wasfound previously for microbial lipoglycans.
more active than a ganglioside containing lignoceric
acid (with 24 carbon atoms, #11) (Figure 1B), althoughResults
as noted above, we cannot exclude the possibility that
differences in solubility or availability are responsibleAcyl Chains Influence Presentation of GM1
for this difference. GM1 with sphinganine, which con-to T Cells
tains only saturated C±C bonds (#12), was less activeThe antigenicity of a series of gangliosides with identical
than sphingosine-containing GM1, which has a doublecarbohydrate moieties, but with different acyl chains,
bond between the fourth and fifth carbons (Figure 1B).was tested by using two T cell clones (Shamshiev et al.,
Sphinganine is less rigid than sphingosine, suggesting1999), which provided similar results throughout these
that the rigidity of one of the lipid tails also may influencestudies. The structures of these compounds are re-
ported in Table 1. The lipid portion of the lipoglycan the presentation efficiency, perhaps by facilitating the
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endosomes/lysosomes. In HeLa cells, it is clearly evi-
dent that the YQ-AA mutation leads to increased levels
of CD1b molecules on the plasma membrane (Figure
2B) relative to the wild type (Figure 2A). Surprisingly, in
the majority of the cells analyzed, a significant number
of intracellular vesicles were labeled by the anti-CD1b
antibodies (Figure 2B), although many of these do not
colocalize with LAMP1. This result is similar to that ob-
tained with a tyrosine to alanine substitution mutant of
CD1b expressed in HeLa cells (Jackman et al., 1998).
Because some features of membrane protein internal-
ization might not be normal in HeLa cells and because
these cells of epithelial origin are not professional APC
that would normally express CD1b, we also tested CD1b
wt and CD1b YQ-AA-transduced THP.1 cells. The alter-
ation in the steady-state distribution of CD1b was much
more dramatic in these cells (Figures 2C and 2D). Intra-
cellular CD1b labeling in the THP.1 CD1b YQ-AA-trans-
duced cell lines was almost completely absent (Figure
2D). In the CD1b wt THP.1 cell line, however, there were
Figure 1. The Structure of GM1 Acyl Chains Influences Presentation many vesicular structures labeled with the anti-CD1b
to T Cells
antibodies (Figure 2C).
(A) GM1 containing only one hydrophobic acyl chain and deacylated Transduced cell lines were sorted to select for cells
GM1 are not antigenic.
expressing similar surface levels of CD1b protein and(B) Intact GM1 is optimal for activation of GM1-specific T cells.
tested in antigen presentation assays. Interestingly,Sphinganine- and C24 acyl-containing GM1 are less active than
CD1b YQ-AA-transduced HeLa cells presented GM1 asnatural GM1.
efficiently as APC transduced with wild-type CD1b (Fig-Dendritic cells were incubated with the indicated doses of different
GSLs before addition of T cells. Released IFNg is shown 6 SD. Data ure 3A). Similar results were obtained with THP.1 cells
are representative of the response of two T cell clones each tested transduced with the same wild-type and mutant CD1b
three times with all compounds. Each time release of TNFa was gene constructs (Figure 3B). These data indicate that
also assessed and showed similar results (data not shown). GM1 can associate with CD1b without being inter-
nalized.
This hypothesis was further tested by using dendritic
proper accommodation of antigen in the CD1b binding cells pulsed with GM1 in different culture conditions that
pocket. should inhibit endosomal uptake and/or processing of
In conclusion, stringent constraints in the ceramide antigens. These conditions include: (1) antigen pulse for
structure control the generation of immunogenic GM1± 2 hr at 188C, a temperature that does not allow recycling
CD1b complexes, the most important being the pres- of membrane proteins (Figure 3C); (2) culture in the pres-
ence of two lipid tails, which presumably anchor GM1 ence of NH4Cl or chloroquine, which prevent acidifica-
to the antigen-presenting molecule. tion of intracellular organelles (Figure 3C); or (3) culture
in the presence of chlorpromazine and monodansylca-
daverine, which inhibit recycling of membrane proteinsGM1 Associates with CD1b on the Cell Surface
(data not shown). All these treatments did not alter thewithout Being Internalized
GM1 antigen presentation capacity of the dendritic cells,The kinetics of the generation of GM1±CD1b complexes
while they affected presentation of PPD by the samewas studied in T cell activation experiments, with APC
APC to MHC class II±restricted and PPD-specific T cellspulsed for different times with GM1. These kinetics are
(data not shown). Finally, dendritic cells were first fixedvery fast, as APC pulsed for only 2 min are capable of
with glutaraldehyde and then pulsed either with GM1some T cell activation, while 1 hr of pulsing led to near
or the control antigen PPD before testing in antigenmaximal T cell stimulation (data not shown). This fast
presentation assays. Fixed dendritic cells efficiently pre-binding and presentation suggested the possibility that
sented GM1 (Figure 3D), while they did not stimulateGM1 is not internalized into APC before binding to CD1b.
HLA-DR-restricted PPD-specific T cells (data not shown).To test this hypothesis, we investigated the presentation
Furthermore, the kinetics of GM1±CD1b complex forma-capacity of cells expressing mutated CD1b molecules
tion are comparable in living and fixed APC (data notthat are not targeted efficiently to endosomes. Previous
shown), indicating that the association of GM1 withstudies have demonstrated that mutation of the tyrosine
CD1b is independent of membrane fluidity and surfacein the YXXZ motifs of the cytoplasmic tails of CD1b
protein mobility. We also could exclude the possibleand CD1d results in defective endosomal targeting and
involvement of carbohydrate-specific receptors in theaccumulation of molecules on the plasma membrane
uptake of GM1. Indeed, galactose, lactose, N-acetylgal-(Sugita et al., 1996; Brossay et al., 1997; Jackman et al.,
actosamine, and mannan, which bind to surface lectins1998; Tangri et al., 1998). We therefore generated stable
and block internalization of glycolipids (Prigozy et al.,cell lines expressing either wild-type CD1b (CD1b wt),
1997), did not inhibit GM1 presentation (data not shown).or a mutated CD1b having YQ-AA substitutions at posi-
tions 311 and 312 in the CD1b cytoplasmic tail (CD1b
YQ-AA). Confocal microscopy was used to colocalize Intact GM1 Is Recognized without Being Processed
An important issue is whether GM1 associates as anCD1b wt and CD1b YQ-AA with the lysosome-associ-
ated membrane protein 1 (LAMP1), a marker for late intact molecule with CD1b, or instead if it is partially
Immunity
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Figure 2. Altered Intracellular Distribution of
CD1b in Cytoplasmic Tail Mutants
Immunofluorescently labeled cells were ana-
lyzed by confocal microscopy. HeLa±CD1b
wt (A) and HeLa±CD1b YQ-AA (B) ±trans-
duced cell lines were labeled with anti-CD1b
mAb (red, left panels) and anti-LAMP1 mAb
(green, middle panels). The right panels dis-
play the overlay of red and green channels
with the colocalization depicted by yellow
signal. The CD1b-FITC labeling of THP.1 cells
is shown for THP.1±CD1b wt (C) and THP.1±
CD1b YQ-AA (D). The images were collected
using the 603 objective with a 2.46 zoom.
degraded before binding to CD1b. As fixed APC effi- serum. This possibility was tested with two approaches.
First, APC were fixed and then pulsed in serum-freeciently present GM1, intracellular processing is not re-
quired. However, processing could occur on the cell conditions to avoid potential GM1 processing by serum
components. In these conditions, efficient presentationsurface through the action of enzymes present in the
Figure 3. GM1 Internalization and Endoso-
mal Acidification Are Not Required for Activa-
tion of GM1-Specific T Cells
(A and B) HeLa cells (A) or THP.1 cells (B)
expressing CD1b wild-type (inverted open tri-
angles), YQ-AA mutant (open squares), or
mock transfected controls (closed triangle)
were incubated with GM1 before addition of
T cells. Dendritic cells were used as positive
control APC (open circle). Figures are repre-
sentative of four experiments with two T cell
clones. Similar results were obtained by mea-
suring release of TNFa (data not shown). Both
wild-type and mutant CD1b transfectants ex-
pressed similar levels of CD1b on cell
surface.
(C) Dendritic cells were incubated at 378C in
the presence of NH4Cl or chloroquine or at
188C for 1 hr and then pulsed with GM1 (10
mM). After extensive washing, these dendritic
cells were used to stimulate T cells.
(D) Dendritic cells were pulsed with GM1 (10
mM) at 378C (pH 7.0) for 2 hr before or after
fixation, and after extensive washing they
were used to stimulate T cells.
(C and D) Similar results were obtained by
measuring release of IFNg and TNFa. Results
are representative of three separate experi-
ments for each condition performed with two
T cell clones.
Recognition of Self-Glycolipids by ab T Cells
259
Figure 4. GM1 Does Not Require Processing
for Presentation
(A) Fixed dendritic cells were pulsed in serum-
free medium with indicated doses of GM1
(open circle) for 2 hr and then used to stimu-
late GM1-specific T cells.
(B) Dendritic cells were incubated for 2 hr with
GM1 (open circle), asialo-GM1 (closed circle),
GM2 (open triangle), asialo-GM2 (closed tri-
angle), GM3 (open square), lactosylceramide
(LacCer, inverted open triangle), or glucosyl-
ceramide (GlcCer, inverted closed triangle)
before addition of T cells. Similar results were
obtained with TNFa ELISA (data not shown).
(C) Stimulation with nonantigenic GSLs does
not induce a state of T cell unresponsiveness.
T cells were first incubated with APC pulsed
with indicated nonstimulatory GSLs (40 mM)
and after 6 hr with GM1-pulsed (20 mM) APC.
(D) GM1 is displaced by other glycolipids. Den-
dritic cells were fixed, then pulsed with GM1
(4 mM), extensively washed, and incubated
with 40 mM of GM2, GM3, LacCer, GlcCer, or
deacylated GM1. After 2 hr, dendritic cells
were extensively washed and used to stimu-
late T cells. Results are representative of four
experiments with two T cell clones.
of GM1 also did occur (Figure 4A). Second, we tested with a 10-fold excess of the nonstimulatory small gangli-
osides before culture with T cells. Using these doses,a set of gangliosides with identical ceramide tails but
having carbohydrate head groups smaller than GM1. no alteration of T cell viability was observed, thus ex-
cluding the possibility that these compounds exert toxicThese compounds represent all the possible products
of the putative processing of GM1 carbohydrates, in- or detergent-like effects. Deacylated GM1, which was
used as negative control (Figure 1A), did not displacecluding asialo-GM1, GM2, asialo-GM2, GM3 (Table 1,
#2±#5), lactosylceramide (#6), and glucosylceramide GM1, while all tested compounds were capable of inhib-
iting the GM1-specific response, although with different(#7). None of these compounds stimulated either of the
two GM1-specific T cell clones (Figure 4B). This effect efficiencies (Figure 4D). One exception was lactosylcer-
amide, which never stimulated the T cell clones, andis not the result of anergic state induced in T cells by
small GSLs. Indeed, when T cells were first stimulated neither did it displace GM1, even after careful solubili-
zation of two preparations from different sources. Awith APC pulsed with small GSLs and after 6 hr with
GM1-pulsed APC, they were fully reactive as control possible explanation for these findings is that both
lactosylceramide preparations contained large fractionscells (Figure 4C). Taken together, these findings indicate
that GM1 is the minimal structure recognized by these (z75%±85%) of C22±24 acyl chains, which, as de-
scribed above (Figure 1B), is not optimal for T cell stimu-T cells and that the terminal galactose IV, N-acetylgalac-
tosamine, and lateral sialic acid all contribute to the lation. Thus, it is likely that, with the exception of lacto-
sylceramide, all tested gangliosides bind to CD1b andGM1 stimulatory epitope.
displace GM1. The lack of antigenicity therefore most
likely is determined by the inability of their carbohy-Reversible Binding of Gangliosides to CD1b
drates to stimulate the TCR of the tested clones.To assess whether nonstimulatory GSLs smaller than
The results from the GM1 displacement experimentsGM1 bind to CD1b, two types of displacement assays
suggest that GM1 is in binding equilibrium with CD1bwere established. In the first assay, a soluble recombi-
and that the binding can be reversed in the presencenant CD1b refolded in the presence of GM1 was used.
of competitors. We used the displacement assay to de-The appropriate refolding of the molecule was confirmed
termine if analogs with one lipid tail, which are not anti-by its capacity to activate only GM1-specific and not T
genic (Figure 1A), also are capable of binding to CD1b.cells with irrelevant specificities (Figures 5A and 5B).
Lyso±GM1 and GM1±acetyl, two GSLs containing onlyThe soluble molecule was used to test displacement of
one acyl chain, completely displaced GM1 from CD1bGM1 by GM2. 3H-labeled GM1 bound to soluble CD1b
on cell surface, while deacylated GM1 did not displacewas displaced by cold GM2 (Figure 5C). In addition,
GM1 (Figure 4D). Cell viability also was not impairedbinding of 3H-labeled GM2 was detected after displace-
under these experimental conditions. Furthermore,ment of cold GM1 (Figure 5D). These experiments dem-
3H-labeled GM1±acetyl displaced cold GM1 and boundonstrate that GM1 and GM2 gangliosides bind to CD1b
to recombinant soluble CD1b (Figure 5E). Therefore,and are readily substituted, although GM2 does not
while GSLs with two acyl chains form immunogenicstimulate the GM1-reactive T cell clones.
complexes with CD1b, GSLs with one acyl chain dis-To extend this information to the other GSLs, we per-
place gangliosides, bind to CD1b, but are not stimula-formed a second displacement assay in which fixed
APC were loaded with GM1, washed, and then pulsed tory for the tested T cell clones.
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up to eight carbohydrates, do not prevent the CD1b-
mediated interaction of these intact compounds with
the TCR.
To further define the epitope stimulating the TCR of
the tested cells, the responses to three additional GM1
analogs, including GM1±alcohol (#14), GalNAc±GD1a
(#15), and GM1±Neu5Gc (#13) were tested. All these
gangliosides have single monosaccharides or chemical
groups added to the GM1 stimulatory core epitope.
GM1±alcohol and GalNAc±GD1a were more stimulatory
than GM1, while GM1±Neu5Gc was as stimulatory as
GM1 (Figure 6C). As with the other GSLs, the same
results were observed using APC pulsed after fixation
and in the absence of serum (Figure 6D), showing that
these active ligands also are not subjected to intracellu-
lar or serum-dependent processing. These data exclude
an important role in T cell interaction of the carboxylic
and methyl groups present on sialic acid as well as of
the hydroxyls in C3 and C4 in the terminal galactose IV.
Discussion
We have carried out a detailed characterization of the
CD1b-mediated recognition of self-GSLs. The recogni-
tion of gangliosides by T lymphocytes may have implica-
tions for the pathogenesis of autoimmune diseases such
as multiple sclerosis (Shamshiev et al., 1999). Addition-
ally, the availability of a large set of purified and synthetic
gangliosides has permitted us to carry out a more pre-
cise analysis of the structural basis for lipid antigen
recognition than has been possible previously. Three
main novel features of the CD1b-mediated recognition
Figure 5. GM1 Bound to Soluble CD1b Stimulates T Cells and Is of self-GSLs have been described in this report. First,Displaced by Other GSLs
we have found that several self-GSLs can readily bind
sCD1b refolded in the presence of GM1 stimulated GM1-specific to CD1b molecules on the cell surface at neutral pH,T cells (A) and not a NK T cell clone recognizing CD1d-a-GalCer
and that glycolipid±CD1b complexes formed in this waycomplexes (B). Aggregated denatured soluble CD1b (aCD1b), BSA,
can stimulate autoreactive T cells. There is no evidenceand GM1 were used as negative control. Similar results were ob-
that internalization into APC augments the T cell re-tained by measuring released TNFa. (C) 3H-labeled GM1 bound to
sponse to GM1 or related compounds. Furthermore,soluble CD1b is displaced by cold GM2. White and black bars indi-
cate radioactivity associated with sCD1b before and after displace- soluble GM1±CD1b complexes are formed at physiologi-
ment, respectively. Curves 1 and 2 show sCD1b elution profiles cal pH in the absence of other proteins, and these com-
before and after displacement, respectively. (D) 3H-labeled GM2 and plexes stimulate antigen-specific T cells. These data,
(E) 3H-labeled GM1±acetyl bound to sCD1b after displacement of together with the evidence from assays carried out using
cold GM1. 3H-labeled GSLs eluting between 3±13 ml represent mi- APC pulsed in serum-free medium suggest that self-celles not binding to CD1b. Results are representative of two sepa-
GSLs can bind to CD1b directly without a need forrate experiments for each condition.
chaperones and/or specific capture proteins. These
properties are in stark contrast to those described for
glycolipids of bacterial origin. Indeed, presentation of
GM1-Specific T Cells Cross-React with a Variety LAM, GMM, and mycolic acids by CD1b occurs only
of Self-GSLs with Complex Oligosaccharides after internalization (Sieling et al., 1995; Jackman et al.,
As the oligosaccharidic portion of GM1 is the minimal 1998), which for LAM requires uptake by the mannose
structure required for forming the epitope recognized receptor (Prigozy et al., 1997) and transport to acidified
by the T cell clones, we asked whether gangliosides endosomes where the encounter with CD1b and antigen
with hydrophilic head groups even bigger than GM1 also processing may occur. Furthermore, microbial glyco-
can be recognized without processing. We tested GD1a lipid binding to soluble CD1b molecules derived from
(Table 1, #16), GD1b (#17), GT1b (#18), and GQ1b (#19), insect cells occurred efficiently only at acidic pH (Ernst
which all differ from GM1 by the presence of additional et al., 1998).
sialic acid residues added to the external galactose IV The predominant localization of CD1b to late endo-
or to galactose II. GT1b, GD1b, and GD1a were slightly somes, in contrast to the localization of CD1a to recy-
more stimulatory than GM1, while GQ1b was as active cling endosomes, has led recently to the hypothesis that
as GM1 (Figure 6A). These gangliosides were also effi- different CD1 molecules are important for the surveil-
ciently presented by fixed APC pulsed in the absence lance of different intracellular compartments (Sugita et
of serum (Figure 6B), thereby excluding the possibility al., 1999). While this is likely to be true, our data show
that intracellular or serum-dependent processing is re- that the binding of some lipid antigens to CD1b does
quired for their recognition. We conclude that the addi- not require acidic pH, and also, that CD1b molecules
are more versatile than previously expected, as they cantional sialic acid residues, generating gangliosides with
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Figure 6. GM1-Specific T Cells Cross-React
with GD1a, GD1b, GT1b, GQ1b, GM1±
Alcohol, GalNAc±GD1a, and GM1±Neu5Gc
(A) Dendritic cells were pulsed with GM1
(open circle), GD1a (inverted open triangle),
GD1b (open square), GT1b (closed triangle),
or GQ1b (open triangle) before addition of T
cells or (C) with GM1 (open circle), GM1±
alcohol (inverted open triangle), GalNAc±
GD1a (open square), and GM1±Neu5Gc
(closed triangle). (B and D) Dendritic cells
were fixed, then pulsed with indicated gangli-
osides (10 mM) for 2 hr at 378C in serum-free
medium, washed extensively, and plated to
stimulate T cells. Data are representative of
the response of two T cell clones each tested
three times with all compounds. Each time
release of TNFa was also assessed and
showed similar results (data not shown).
acquire antigens on the cell surface as well as in late tails of the ceramide are inserted into the CD1b hy-
drophobic pockets (Zeng et al., 1997) with much of theendosomes.
Our studies also show how the structure of the lipid presented ganglioside antigen exposed above the CD1b
groove. In light of this, there are several possible modelstails may influence CD1b binding and presentation. In
addition to the number of lipid tails, the length of the as to how the TCR interaction occurs. First, specificity
could result because the TCR recognizes mostly carbo-fatty acid is important, with the GM1 compound with
stearic acid having the highest T cell stimulatory capac- hydrate, with relatively little contact with the CD1b a
helices. We consider this unlikely, because the TCRs ofity. In the GMM model, by contrast, the natural GMM
from mycobacteria containing C80 mycolic acid, or syn- the same T cell clones used in this study require cognate
interaction with CD1b, as shown by mutagenesis of resi-thetic GMM containing C32 mycolic acid, both activate
T cells (Moody et al., 1997). The C80 compound is too dues in the CD1b a helices that point toward the TCR
(A. Melian et al., submitted). Second, the TCR CDR3long to fit into the CD1b groove, and partial degradation
of the chain after uptake into APC might occur. An addi- loops might form a large cavity that can accommodate
the relatively complex carbohydrate part of the ganglio-tional requirement for proper structure of one lipid chain
is suggested by the results obtained with the GM1 ana- sides. Third, the ganglioside sugars might assume a
lateral conformation perpendicular to the CD1 a helices,log containing sphinganine instead of sphingosine. The
double bond present in the sphingosine base might con- thus making difficult the interaction with the CDR3 loops.
An additional possibility is that the complex oligosac-fer a more favorable conformation to the ceramide, likely
facilitating anchoring to CD1b. charide present in GM1 and other stimulatory ganglio-
sides protrudes out of the CD1b binding groove. ThisThe second novel finding that we report is that self-
GSLs with relatively complex oligosaccharides, includ- model is similar to TCR recognition of long peptides
that bind to MHC class II molecules and that may extending those with up to eight sugars, are presented without
being processed. In fact, the minimal epitope required beyond the groove (Stern et al., 1994) and might explain
the conserved contact of TCR with monosaccharides infor antigen recognition by the clones analyzed in this
study is the GM1 pentasaccharide, with the external the GM1 core epitope present in all stimulatory ganglio-
sides.galactose IV required. The core epitope is not present
in gangliosides smaller than GM1, which indeed are not Whatever the mechanism, a remarkable observation
from our experimental data is that the same TCR recog-stimulatory, although they bind to CD1b. Instead, the
same epitope is present in other GSLs that are bigger nizes carbohydrate epitopes shared by a variety of self-
GSLs. The GM1 epitope recognized by the autoreactivethan GM1 and that stimulate the two T cell clones used
in this study. This is in agreement with the known GM1 T cells is also present in bacterial carbohydrates (Pren-
dergast et al., 1998), suggesting a possible cross-reac-and GD1a conformations, detected by NMR, which
show a high degree of three-dimensional similarity in tivity between self- and microbial glycolipid antigens.
Based upon these considerations, we propose that anti-both molecules (Acquotti et al., 1994). Furthermore, simi-
lar conformations are also suggested by the structure gen mimicry, which is a potentially important mechanism
for autoimmune disease pathogenesis (Albert and In-models of these gangliosides (our unpublished data).
Given all these similarities in the structure relevant for man, 1999), also may apply to the CD1-mediated recog-
nition of glycolipid antigens.T cell activation, the important question remains as to
how the TCR of the reactive clones interacts with gangli- The third important finding is that the interaction of
the hydrophobic acyl chains of ceramide with CD1b isoside±CD1b complexes. It is most likely that the lipid
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mAbs specific for CD1b (WM-25, Immunokontakt, Lugano, Switzer-a very dynamic or highly reversible process, in contrast
land), CD1a (OKT6, ATCC CRL8019), and CD1c (L161, Instrumenta-to the more stable complexes that characterize the bind-
tion Laboratory, Schlieren, Switzerland). APC were always .90%ing of peptides to MHC class I and class II molecules.
positive for these markers. Immunofluorescence was performed asThis suggests that, compared to peptides, a relatively
described (Shamshiev et al., 1999) using a FACScan flow cytometer
high concentration of self-GSL antigen may be required (Becton Dickinson).
for T cell stimulation. However, the significant precursor
frequency of self-GSL-reactive T cells in normal donors Plasmids, Mutagenesis, and Generation of Stable
and its increase in multiple sclerosis patients (Sham- CD1b Cell Lines
shiev et al., 1999) suggest that this concentration of The CD1b wild-type (wt) and CD1b YQ-AA coding regions were
antigen is likely to occur in vivo. Interestingly, a variety generated by PCR amplification using a common 59 oligonucleotide
primer, and two different 39 primers. In the mutant, cytoplasmicof nonantigenic glycolipids, containing either one or two
tyrosine (Y)-311 and glutamine (Q)-312 were replaced with alaninesacyl chains, can displace GM1 molecules previously
(AA). The PCR products were subcloned into the pCR3.1 vectorbound to CD1b. This implies that the groove of CD1b
(Clontech, San Diego, CA) and sequenced. PmeI-restricted insertscan be easily accessed by exogenous glycolipids, even
were subcloned into the SnaBI site of the pBabe-puro retroviralwhen GM1 is already bound to CD1b, and also that GM1
expression plasmid (Morgenstern and Land, 1990). Stable cell lines
analogs with only one acyl chain interact with CD1b. expressing CD1b wt and CD1b YQ-AA were generated by retroviral
This single chain interaction does not generate TCR- transduction as described (Soneoka et al., 1995). The pBabe-puro
stimulatory complexes because it is not stable enough CD1b wt or YQ-AA plasmids were cotransfected into 293T cells with
or, alternatively, because the presence of only one acyl pHit60 (gag-pol expression plasmid) and pCG (VSV-g expression
plasmid) by calcium phosphate±DNA coprecipitation. The trans-chain prevents the appropriate positioning of the carbo-
fected cells were shocked for 12 hr with sodium butyrate followedhydrate core epitope. Regardless of the mechanism,
by the addition of fresh media for 16 hr. The virus-containing super-presentation by CD1 molecules could be subject to fine
natants were filtered through 0.45 mm filters and retroviruses titeredregulation by the levels of circulating ligands. It remains
by transducing HeLa cells and drug selecting with puromycin. Toto be investigated whether this particular regulatory sys-
generate stable cell lines expressing CD1b wt and CD1b YQ-AA,
tem, carried out by competing self-compounds, is ade- HeLa and THP.1 cells were seeded in 24-well plates at 2 3 105 cells/
quate to displace self-GSLs, thereby preventing presen- well. High-level expression was generated by transducing cells in
tation of self-antigens, but not microbial ligands. the presence of polybrene (4 mg/ml) with 1 ml of retrovirus three
times in succession. After selection, the high-expressing cells were
selected by fluorescence-activated cell sorting using the WM25 anti-Experimental Procedures
CD1b mAb.
Antigens
GSLs were purchased from different companies or purified as re- Immunofluorescent Labeling and Confocal Imaging
ported. In some cases, the same GSLs obtained from different For immunofluorescent labeling, cells were seeded in 8-well perma-
sources were tested to exclude the presence of active contami- nox chamber slides at 2 3 105 cells/well and 1 3 105 cells/well for
nants. From Matreya Inc. (Pleasant Gap, PA), we purchased the THP.1- and HeLa-transduced cell lines, respectively. After culturing
following GSLs purified from bovine or porcine brain: GM1 (#1061), overnight, the cells were rinsed with PBS and fixed with 4% formal-
asialo-GM1 (#1064), GM2 (#1502), GM3 (#1503), GD1a (#1062), GD1b dehyde in PBS. After quenching with 0.2 M glycine, the cells were
(#1501), GT1b (#1063), GQ1b (#1516), lyso±GM1 (#1518), lactosylcer- permeabilized with 0.1% saponin for 8 min. The cells were incubated
amide (#1507 and #1500, with z84% and z75%, respectively, of in 10% donkey serum for 20 min prior to the addition of the anti-
C20±24 acyl chains). The following purified gangliosides purified CD1b mAbs. Double labeling was performed by incubating with
from bovine brain were purchased from Sigma (Buchs, Switzerland): goat-anti mouse Fab (Jackson Immunoresearch, West Grove, PA)
GM1 (#G7641), asialo-GM1 (#G3018), GM2 (#G8397), and asialo- as previously described (Prigozy et al. 1997). LAMP1 molecules were
GM2 (#G9398). GM1, GM2, and asialo-GM2 were .95% pure, and detected with a biotinylated anti-LAMP1 mAb (PharMingen, San
asialo-GM1 was .98% pure. Glucosylceramide (#49108, .98% Diego, CA) followed by FITC-conjugated streptavidin. Cells were
pure, from bovine brain) was purchased from Fluka (Buchs, Switzer- analyzed using a Nikon microscope 603 objective and an MRC 1024
land). The following gangliosides were purified from bovine brain ES confocal system (Bio-Rad, London, UK). A minimum of 16 0.5
and in some cases modified in our laboratory (S. Sonnino): GD1a mm optical z sections were collected and vertically projected using
and GalNAc±GD1a (Acquotti et al., 1994), GM1±Neu5Gc (containing the Lasersharp image processing software. For double labelings,
N-glycolylneuraminic acid instead of N-acetylneuraminic acid) (Son- the colocalization was depicted by yellow signal.
nino et al., 1988), deacylated-GM1 (GM1 without the lipid tails) (Wie-
gandt and Bucking, 1970), GM1±sphinganine (GM1 with sphinganine Antigen Presentation Assays
instead of sphingosine) (Sonnino et al., 1985), GM1±alcohol (sialic Dendritic cells, CD1b wild-type, CD1b YQ-AA, or mock transfected
acid with CH2OH instead of COOH) (Li et al., 1984). Semisynthetic HeLa and THP.1 cells (6 3 104/well in triplicate), in RPMI-1640 me-
GM1±acetyl and GM1±C24 (containing an acetyl group and a ligno- dium containing 10% FCS, were preincubated for 2 hr at 378C with
ceric acid as acyl moiety, respectively) were prepared as described sonicated antigen (0.01±30 mM) before addition of T cells (6 3 104/
(Sonnino et al., 1985, 1990). 3H-labeled GM1, GM2, and lyso±GM1 well). Supernatants were harvested after 48 hr, and cytokine levels
were prepared as described (Sonnino et al., 1996). GM1 and other were measured by ELISA.
GSLs were 98%±99% pure according to TLC analysis. The critical Fixation of APCs was performed using 0.05% glutaraldehyde
micellar concentrations of GM1, GM2, GM3, GD1a, GD1b, GT1b, (Fluka) for 30 s at 378C with vortexing. Further fixation was immedi-
and GQ1b are similar (Sonnino et al., 1994) and therefore are not ately blocked by addition of an equal volume of 0.2 M lysine (Fluka).
critical parameters responsible for the different results we obtained Cells were washed three times and then used in antigen presentation
with these compounds. assays. The efficiency of fixation was controlled by 3H-thymidine
incorporation of fixed cells and by PPD stimulation of PPD-specific
and MHC class II±restricted T cells.T Cell Clones and Antigen-Presenting Cells
Ganglioside GM1-specific and CD1b-restricted T cell clones GG33A To investigate the kinetics of internalization, dendritic cells were
incubated at 378C with GM1 (20 mM), washed at different time points,and GG123 were used in all experiments (Shamshiev et al., 1999).
Dendritic cells were used as APC in most experiments and were fixed as above, and cocultured with T cells. In some experiments,
APC were first fixed, then washed and pulsed with GSLs for 2 hrderived from peripheral blood mononuclear cells as described (Por-
celli et al., 1992). Before each experiment, the percentage of den- before further washing and addition of T cells. In other experiments,
dendritic cells were incubated at 188C, or at 378C in the presencedritic cells was monitored by immunofluorescence analysis using
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of NH4Cl (40 mM), chloroquine (80 mM), chlorpromazine (10 mg/ml), S.T., and Brenner, M.B. (1994). Recognition of a lipid antigen by
CD1-restricted ab1 T cells. Nature 372, 691±694.or monodansylcadaverine (500 mM) (all purchased from Sigma) for
1 hr before addition of GM1 (10 mM). Beckman, E.M., Melian, A., Behar, S.M., Sieling, P.A., Chatterjee,
D., Furlong, S.T., Matsumoto, R., Rosat, J.P., Modlin, R.L., and Por-
Generation of Soluble CD1b celli, S.A. (1996). CD1c restricts responses of mycobacteria-specific
cDNA coding for soluble CD1b was amplified by RT-PCR using a T cells. Evidence for antigen presentation by a second member of
39 primer starting at position 939 before the transmembrane region. the human CD1 family. J. Immunol. 157, 2795±2803.
After sequencing, it was subcloned in the expression vector PGMT7.
Brossay, L., Jullien, D., Cardell, S., Sydora, B.C., Burdin, N., Modlin,A similar construct was generated to express the full-length cDNA
R.L., and Kronenberg, M. (1997). Mouse CD1 is mainly expressedof human b2m. Recombinant proteins were expressed in BL21 LysS
on hemopoietic-derived cells. J. Immunol. 159, 1216±1224.bacteria and recovered in inclusion bodies. In vitro refolding of
Brossay, L., Chioda, M., Burdin, N., Koezuka, Y., Casorati, G., Della-CD1b, b2m, and GM1 was done at pH 7.2 by dilution as described
bona, P., and Kronenberg, M. (1998). CD1d-mediated recognition of(Garboczi et al., 1992). After concentration on Amicon 10K, the re-
an a-galactosylceramide by natural killer T cells is highly conservedfolded complex (sCD1b) was purified from aggregated proteins
through mammalian evolution. J. Exp. Med. 188, 1521±1528.(aCD1b) on a HiLoad 16/60 Superdex 200 column (Pharmacia). The
purity of soluble protein was .90% as assessed by Coomassie Burdin, N., and Kronenberg, M. (1999). CD1-mediated immune re-
staining. The correct association with b2m and refolding was con- sponses to glycolipids. Curr. Opin. Immunol. 11, 326±331.
firmed by sandwich ELISA in which anti-b2m and conformational
Calabi, F., Jarvis, J.M., Martin, L., and Milstein, C. (1989). Two
dependent anti-CD1b mAbs (WM25) were used as capture and re-
classes of CD1 genes. Eur. J. Immunol. 19, 285±292.
vealing reagents.
Ernst, W.A., Maher, J., Cho, S., Niazi, K.R., Chatterjee, D., Moody,
D.B., Besra, G.S., Watanabe, Y., Jensen, P.E., Porcelli, S.A., et al.Stimulation of T Cells with sCD1b and Displacement
(1998). Molecular interaction of CD1b with lipoglycan antigens. Im-of Bound GM1
munity 8, 331±340.The sCD1b or control proteins were immobilized at 10 mg/ml and
used to stimulate T cells (8 3 104/well) for 48 hr in the presence of Garboczi, D.N., Hung, D.T., and Wiley, D.C. (1992). HLA-A2-peptide
1 ng/ml PMA. Released lymphokines were measured by ELISA. For complexes: refolding and crystallization of molecules expressed in
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of cold GM1. After purification and concentration, it was incubated 63±74.
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